Investors Corporate Report Stock Press Releases Annual Meeting & Proxy Information > Annual Reports SEC Filings Investor Channel Investor FAQ Investor Contact Email Alerts
Annual Reports & Proxy Information
Requests for original copies of Radient Pharmaceutical's Annual Report and Proxy Statement can be made by contacting Paul Knopick at or 949.707.5365.
